To the best of our knowledge, this is the first report which clearly demonstrated a tumor-suppressive role for YY1 in CRC, and, in particular, its positive role in chemosensitivity (as YY1 higher levels were associated with greater CRC cellular death in responder cell lines). The gene discussed is YY1; the disease is neoplasm.